drugset

drugset / Trial / NCT00329810

Effect on Cognitive Function of a Treatment With Aripiprazole

NCT00329810 ↗

Phase 4 Completed 500 enrolled Otsuka Pharmaceutical Development & Commercialization, Inc. Otsuka America Pharmaceutical · collab

Non-randomizedSingle-groupOpen-labelTreatment

Summary

To evaluate the effectiveness of Aripiprazole after 12 weeks of therapy for Schizophrenic patients.

Timeline

Start: 2005-03
Primary completion: 2006-03
Completion: 2006-03

Publications

Bervoets C, Morrens M, Vansteelandt K, Kok F, de Patoul A, Halkin V, Pitsi D, Constant E, Peuskens J, Sabbe B. Effect of aripiprazole on verbal memory and fluency in schizophrenic patients : results from the ESCAPE study. CNS Drugs. 2012 Nov;26(11):975-82. doi: 10.1007/s40263-012-0003-4.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Aripiprazole	Other / unclassified	15 mg	Oral

Indications